Ovid Therapeutics was founded in 2014.
Ovid Therapeutics was incorporated in the state of Delaware in April, 2014.
441 Ninth Avenue 14th Floor New York, NY 10001 United States
Ovid Therapeutics’ fiscal year-end is December 31st
Ovid’s shares of common stock first started trading on the NASDAQ Global Select Market on May 5, 2017.
Ovid Therapeutics' common stock is traded on the NASDAQ Global Select Market under the symbol “OVID”.
Shares can be purchased through a stockbroker of your choice.
Ovid Therapeutics does not offer a direct stock purchase plan.
Currently, Ovid Therapeutics does not pay a dividend or offer a dividend reinvestment program.
Communication regarding transfer requirements, lost certificates, and change of address should be directed to:
Computershare Trust Company, N.A. P.O. Box 30170 College Station, TX 77842-3170
Phone: (877) 373-6374 (U.S., Canada and Puerto Rico) (781) 575-2879 (non-U.S.)
Email: web.queries@computershare.com (please include a reference to “Ovid Therapeutics”)
Our independent registered public accounting firm is KPMG LLP.
Ovid Therapeutics press release archives can be viewed in the Press Releases section.
Sign up for email alerts here.
Those documents can be viewed here.
For investor related questions please send an email to malexander@ovidrx.com.